3rd Jan 2008 16:38
GlaxoSmithKline PLC03 January 2008 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the directors' interests in the OrdinaryShares and American Depository Shares (ADSs) of GlaxoSmithKline plc. On 31 December 2007, the Company's Non-Executive Directors were provisionallyallocated the following awards over Ordinary Shares and American DepositoryShares (ADSs) in the Company through the Annual Re-investment of Dividends paidthroughout 2007: SmithKline Beecham Non-Executive Directors Retainer Fee and Share AllocationAward - Annual Dividend Reinvestment Non-Executive Director No. of Ordinary Average Price (£) SharesSir Ian Prosser 42.361 12.8433 GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected ShareAward - Annual Dividend Reinvestment Non-Executive Director No. of Ordinary Average Price (£) No. of ADSs Average Price Shares ($)Sir Christopher Gent 728.17 12.8433Prof Sir Roy Anderson - -Dr Stephanie Burns 5.92 50.82Mr Lawrence Culp 357.82 50.82Sir Crispin Davis 729.43 12.8433Sir Deryck Maughan 278.73 50.82Dr Daniel Podolsky 43.48 50.82Sir Ian Prosser 767.65 12.8433Dr Ronaldo Schmitz 666.93 12.8433Mr Tom de Swaan 34.26 12.8433Sir Robert Wilson 191.97 12.8433 The Company and the Non-Executive Directors were informed of these allocationson 2 January 2008. This notification relates to transactions notified in accordance with Disclosureand Transparency Rule 3.1.4R(1)(a). S M Bicknell Company Secretary 3 January 2008 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline